Revance Therapeutics, Inc. (RVNC)
USD 3.65
(0.0%)
USD 3.65
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 630.05 Million USD | 10.67% |
| 2022 | 569.3 Million USD | 23.04% |
| 2021 | 462.69 Million USD | 33.75% |
| 2020 | 345.93 Million USD | 201.34% |
| 2019 | 114.79 Million USD | 42.21% |
| 2018 | 80.72 Million USD | 200.61% |
| 2017 | 26.85 Million USD | -1.59% |
| 2016 | 27.28 Million USD | 20.91% |
| 2015 | 22.57 Million USD | 40.19% |
| 2014 | 16.1 Million USD | -91.07% |
| 2013 | 180.19 Million USD | -21.71% |
| 2012 | 230.15 Million USD | 17.78% |
| 2011 | 195.41 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 606.79 Million USD | -3.69% |
| 2024 Q2 | 624.53 Million USD | 2.92% |
| 2023 Q2 | 570.74 Million USD | -0.65% |
| 2023 Q1 | 574.47 Million USD | 0.91% |
| 2023 Q4 | 630.05 Million USD | -1.35% |
| 2023 FY | 630.05 Million USD | 10.67% |
| 2023 Q3 | 638.68 Million USD | 11.9% |
| 2022 Q1 | 614 Million USD | 32.7% |
| 2022 Q2 | 564.51 Million USD | -8.06% |
| 2022 FY | 569.3 Million USD | 23.04% |
| 2022 Q4 | 569.3 Million USD | 0.6% |
| 2022 Q3 | 565.87 Million USD | 0.24% |
| 2021 FY | 462.69 Million USD | 33.75% |
| 2021 Q4 | 462.69 Million USD | 0.22% |
| 2021 Q1 | 431.7 Million USD | 24.79% |
| 2021 Q3 | 461.66 Million USD | 1.55% |
| 2021 Q2 | 454.64 Million USD | 5.31% |
| 2020 Q2 | 320.46 Million USD | 12.62% |
| 2020 Q1 | 284.55 Million USD | 147.87% |
| 2020 FY | 345.93 Million USD | 201.34% |
| 2020 Q3 | 339.29 Million USD | 5.88% |
| 2020 Q4 | 345.93 Million USD | 1.96% |
| 2019 FY | 114.79 Million USD | 42.21% |
| 2019 Q4 | 114.79 Million USD | 0.23% |
| 2019 Q3 | 114.53 Million USD | 6.69% |
| 2019 Q1 | 103.37 Million USD | 28.05% |
| 2019 Q2 | 107.35 Million USD | 3.85% |
| 2018 Q3 | 50.95 Million USD | 3.42% |
| 2018 FY | 80.72 Million USD | 200.61% |
| 2018 Q4 | 80.72 Million USD | 58.43% |
| 2018 Q2 | 49.26 Million USD | 2.35% |
| 2018 Q1 | 48.13 Million USD | 79.26% |
| 2017 Q1 | 30.78 Million USD | 12.8% |
| 2017 Q2 | 27.66 Million USD | -10.14% |
| 2017 Q3 | 27.12 Million USD | -1.93% |
| 2017 Q4 | 26.85 Million USD | -1.01% |
| 2017 FY | 26.85 Million USD | -1.59% |
| 2016 Q4 | 27.28 Million USD | 4.39% |
| 2016 Q2 | 21.23 Million USD | -4.13% |
| 2016 Q3 | 26.14 Million USD | 23.12% |
| 2016 Q1 | 22.14 Million USD | -1.87% |
| 2016 FY | 27.28 Million USD | 20.91% |
| 2015 Q4 | 22.57 Million USD | -2.54% |
| 2015 Q2 | 22.37 Million USD | 82.44% |
| 2015 FY | 22.57 Million USD | 40.19% |
| 2015 Q1 | 12.26 Million USD | -23.83% |
| 2015 Q3 | 23.15 Million USD | 3.5% |
| 2014 Q3 | 21 Million USD | -15.32% |
| 2014 Q1 | 28.22 Million USD | -84.34% |
| 2014 FY | 16.1 Million USD | -91.07% |
| 2014 Q4 | 16.1 Million USD | -23.36% |
| 2014 Q2 | 24.8 Million USD | -12.1% |
| 2013 Q4 | 180.19 Million USD | 337.77% |
| 2013 Q3 | 41.16 Million USD | 0.0% |
| 2013 Q1 | 47.03 Million USD | -79.56% |
| 2013 FY | 180.19 Million USD | -21.71% |
| 2012 FY | 230.15 Million USD | 17.78% |
| 2012 Q4 | 230.15 Million USD | 0.0% |
| 2011 FY | 195.41 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -87.642% |
| Alkermes plc | 933.53 Million USD | 32.509% |
| Agenus Inc. | 462.29 Million USD | -36.289% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 84.445% |
| Aptorum Group Limited | 5.25 Million USD | -11885.722% |
| Ardelyx, Inc. | 130.76 Million USD | -381.832% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -31.704% |
| Bicycle Therapeutics plc | 224.41 Million USD | -180.759% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -383.878% |
| ChromaDex Corporation | 26.5 Million USD | -2276.86% |
| Chimerix, Inc. | 19.74 Million USD | -3090.975% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1691.102% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -768.243% |
| CRISPR Therapeutics AG | 346.76 Million USD | -81.694% |
| Precision BioSciences, Inc. | 140.92 Million USD | -347.103% |
| Dyadic International, Inc. | 2.34 Million USD | -26818.067% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3774.181% |
| Fortress Biotech, Inc. | 165.93 Million USD | -279.693% |
| Lantern Pharma Inc. | 2.73 Million USD | -22897.487% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -781.447% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -17755.118% |
| Incyte Corporation | 1.59 Billion USD | 60.43% |
| IO Biotech, Inc. | 17.55 Million USD | -3488.847% |
| Jaguar Health, Inc. | 45.86 Million USD | -1273.693% |
| Novavax, Inc. | 2.57 Billion USD | 75.506% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1647.346% |
| Opthea Limited | 264.6 Million USD | -138.116% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -382.038% |
| ContextLogic Inc. | 206 Million USD | -205.853% |
| MiMedx Group, Inc. | 96.33 Million USD | -554.062% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1212.019% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -17754.298% |
| NextCure, Inc. | 14.99 Million USD | -4101.227% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -15487.778% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -9336.244% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1248.035% |
| Vaxcyte, Inc. | 167.44 Million USD | -276.269% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1794.391% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -167.866% |
| Pharming Group N.V. | 244.07 Million USD | -158.143% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -5184.835% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -393.038% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -9435.816% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -9435.816% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -664.327% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -9384.54% |
| Acelyrin, Inc. | 86.35 Million USD | -629.631% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -48394.313% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4281.793% |
| Summit Therapeutics Inc. | 125.25 Million USD | -403.012% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6546.883% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1098.49% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -816.088% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -315.847% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -32111.554% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -47075.426% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -177.764% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6626.358% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -177.016% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -27.411% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5672.934% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2190.204% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -5105.07% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -29.481% |
| Immix Biopharma, Inc. | 3.72 Million USD | -16828.929% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1566.291% |
| MEI Pharma, Inc. | 8.35 Million USD | -7441.089% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2071.491% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -81.27% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -331.934% |
| Fortress Biotech, Inc. | 165.93 Million USD | -279.693% |
| Precigen, Inc. | 41.64 Million USD | -1412.962% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1161.883% |
| AlloVir, Inc. | 45.01 Million USD | -1299.662% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -383.407% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -357.226% |
| ImmuCell Corporation | 18.81 Million USD | -3248.696% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2132.19% |
| Onconetix, Inc. | 23.18 Million USD | -2618.006% |
| PureTech Health plc | 125.58 Million USD | -401.706% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6939.754% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1737.868% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -25669.243% |
| Seer, Inc. | 39.36 Million USD | -1500.554% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -918.951% |
| Innoviva, Inc. | 568.55 Million USD | -10.818% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2214.008% |
| ESSA Pharma Inc. | 3.49 Million USD | -17927.044% |
| GlycoMimetics, Inc. | 6.9 Million USD | -9028.532% |
| GT Biopharma, Inc. | 6.63 Million USD | -9398.839% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -138.306% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -131.395% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -649.837% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -6346.266% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2219.033% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -19432.001% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -754.119% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3885.514% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5607.209% |
| Soligenix, Inc. | 7.27 Million USD | -8560.705% |
| Century Therapeutics, Inc. | 175.94 Million USD | -258.108% |
| Kura Oncology, Inc. | 51.66 Million USD | -1119.577% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -419.498% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -15144.568% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -9426.335% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -149.431% |
| Autolus Therapeutics plc | 263.9 Million USD | -138.742% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5910.857% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -609.038% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1243.436% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -78.56% |
| GRI Bio, Inc. | 2.69 Million USD | -23261.439% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -77724.811% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1926.496% |
| IGM Biosciences, Inc. | 220.17 Million USD | -186.16% |
| INmune Bio, Inc. | 18.86 Million USD | -3240.356% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -145.657% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2264.922% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -23077.48% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -19107.528% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -977.851% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -555.225% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -137.996% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 23.446% |
| Verastem, Inc. | 71.18 Million USD | -785.099% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1181.231% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1533.205% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1187.62% |
| Histogen Inc. | 5.69 Million USD | -10959.47% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -14266.501% |
| Surrozen, Inc. | 8.14 Million USD | -7635.519% |
| Organovo Holdings, Inc. | 2.74 Million USD | -22827.875% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -200646.197% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1020.504% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3715.758% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1132.918% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -76097.491% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -397.185% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5726.539% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -317.564% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -24064.735% |
| Apollomics, Inc. | 14.15 Million USD | -4351.763% |
| Amarin Corporation plc | 279.58 Million USD | -125.353% |
| Mesoblast Limited | 188.79 Million USD | -233.721% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4353.336% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -248.507% |
| Synaptogenix, Inc. | 5.52 Million USD | -11294.548% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -9377.407% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -270.387% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7262.905% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -35751.856% |
| Exelixis, Inc. | 678.44 Million USD | 7.132% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2542.639% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -284.074% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -6.033% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5799.307% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -38705.851% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1518.563% |
| Gritstone bio, Inc. | 125.91 Million USD | -400.368% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4193.118% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -12281.69% |
| Avid Bioservices, Inc. | 275.66 Million USD | -128.557% |
| Insmed Incorporated | 1.66 Billion USD | 62.085% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -8088.927% |
| MediWound Ltd. | 27.18 Million USD | -2217.497% |
| OmniAb, Inc. | 87.4 Million USD | -620.89% |
| Alector, Inc. | 487.66 Million USD | -29.198% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -56.165% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3319.582% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1541.931% |
| Zai Lab Limited | 240.17 Million USD | -162.331% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2055.74% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -562.682% |
| Immunic, Inc. | 25.36 Million USD | -2383.672% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -810.015% |
| Veracyte, Inc. | 93.71 Million USD | -572.284% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -23978.591% |
| FibroGen, Inc. | 585.72 Million USD | -7.568% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3524.564% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -96375.448% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -11040.707% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 91.771% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7585.509% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -649.873% |
| TG Therapeutics, Inc. | 169.08 Million USD | -272.628% |
| Galecto, Inc. | 5.89 Million USD | -10586.194% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -7505.722% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 75.937% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2086.032% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4892.14% |
| XBiotech Inc. | 8.39 Million USD | -7403.37% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4193.118% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1084.765% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -73.519% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2243.617% |
| Theravance Biopharma, Inc. | 169 Million USD | -272.807% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 48.169% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -25.904% |
| Vaxxinity, Inc. | 30.94 Million USD | -1936.123% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 35.212% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -10346.805% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 15.455% |
| NexImmune, Inc. | 5.08 Million USD | -12292.393% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -169546.79% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -20390.704% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 91.135% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -12124.57% |
| Scopus BioPharma Inc. | 7.45 Million USD | -8352.124% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2296.204% |
| Ainos, Inc. | 7.39 Million USD | -8420.949% |
| Pluri Inc. | 34.11 Million USD | -1747.027% |
| Prothena Corporation plc | 135.01 Million USD | -366.651% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -159.173% |
| Celularity Inc. | 102.92 Million USD | -512.129% |
| Rallybio Corporation | 9.43 Million USD | -6577.173% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2477.451% |
| MeiraGTx Holdings plc | 319.99 Million USD | -96.899% |
| Omeros Corporation | 403.25 Million USD | -56.244% |
| Humacyte, Inc. | 114.67 Million USD | -449.42% |
| Immunocore Holdings plc | 228.15 Million USD | -176.15% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -12824.267% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -721.029% |
| Blueprint Medicines Corporation | 918.64 Million USD | 31.414% |
| CalciMedica, Inc. | 4.02 Million USD | -15541.956% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3510.234% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -308.749% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -634.188% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -126.808% |
| Pulmatrix, Inc. | 15.96 Million USD | -3846.99% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3894.535% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2460.587% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -151.211% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1140.613% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 47.957% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1882.374% |
| Nutriband Inc. | 1.07 Million USD | -58297.155% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5825.496% |
| Vor Biopharma Inc. | 59.1 Million USD | -966.016% |
| Roivant Sciences Ltd. | 773.95 Million USD | 18.592% |
| Evogene Ltd. | 17.99 Million USD | -3402.268% |
| ProKidney Corp. | 29.21 Million USD | -2056.551% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -775.336% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -89272.084% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 66.644% |
| CorMedix Inc. | 11.91 Million USD | -5186.818% |
| BioLineRx Ltd. | 50.7 Million USD | -1142.669% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -321.559% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -612.405% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1181.596% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1922.508% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3407.727% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -405.518% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -11043.58% |
| MediciNova, Inc. | 3.89 Million USD | -16090.4% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3346.895% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -41785.443% |
| GeoVax Labs, Inc. | 3.51 Million USD | -17799.98% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -58.601% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1952.975% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 76.851% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3847.237% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1919.352% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -973.645% |
| Absci Corporation | 58.3 Million USD | -980.643% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3207.738% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1865.124% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -753.853% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -620.206% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1765.733% |
| Allakos Inc. | 74.79 Million USD | -742.402% |
| Imunon, Inc. | 8.53 Million USD | -7286.008% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2700.133% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -448.774% |
| BioAtla, Inc. | 48.98 Million USD | -1186.2% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5799.307% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -22572.112% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -382.419% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4332.346% |
| XOMA Corporation | 145.58 Million USD | -332.792% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1771.552% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -816.328% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1894.044% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -919.132% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1301.219% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1201.719% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -21853.24% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7623.175% |
| Akari Therapeutics, Plc | 4.58 Million USD | -13644.721% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3452.999% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 61.802% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -155890.473% |
| UroGen Pharma Ltd. | 243.52 Million USD | -158.726% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -96.227% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -22715.309% |
| Orgenesis Inc. | 35.53 Million USD | -1673.063% |
| Entera Bio Ltd. | 1.37 Million USD | -45589.485% |
| GH Research PLC | 6.7 Million USD | -9302.447% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -9165.559% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3246.744% |
| Xencor, Inc. | 283.55 Million USD | -122.196% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -21002.699% |
| Replimune Group, Inc. | 113.21 Million USD | -456.52% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -16669.684% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -508.575% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -155890.473% |
| Portage Biotech Inc. | 4.45 Million USD | -14058.607% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -41785.443% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2633.44% |
| OncoCyte Corporation | 49.29 Million USD | -1178.06% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -15130.546% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -78905.723% |
| Purple Biotech Ltd. | 10 Million USD | -6197.431% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -10789.354% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1000.327% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4986.026% |
| HilleVax, Inc. | 78.9 Million USD | -698.462% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -12376.396% |
| Tharimmune, Inc. | 1.81 Million USD | -34613.06% |
| Genprex, Inc. | 3.25 Million USD | -19261.332% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2223.308% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -11933.193% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -305753.398% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -175624.868% |
| OKYO Pharma Limited | 7.42 Million USD | -8390.38% |
| Savara Inc. | 37.19 Million USD | -1594.069% |
| Curis, Inc. | 57.61 Million USD | -993.623% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2292.941% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1507.299% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -43532.825% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2926.361% |
| BeiGene, Ltd. | 2.23 Billion USD | 71.794% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2859.436% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -140.116% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2861.634% |
| Erasca, Inc. | 78.61 Million USD | -701.488% |
| bluebird bio, Inc. | 424.62 Million USD | -48.38% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -96055.067% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 66.665% |
| DBV Technologies S.A. | 42.8 Million USD | -1372.098% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -96055.067% |
| Moderna, Inc. | 4.57 Billion USD | 86.219% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8907.262% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -37946.981% |
| Molecular Templates, Inc. | 31.17 Million USD | -1921.295% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3591.025% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -7.134% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -406.05% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2196.381% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1628.27% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1032.485% |
| MacroGenics, Inc. | 154.2 Million USD | -308.579% |
| RenovoRx, Inc. | 4.46 Million USD | -14007.882% |
| Adicet Bio, Inc. | 37.12 Million USD | -1597.355% |
| Prime Medicine, Inc. | 60.78 Million USD | -936.621% |
| Aditxt, Inc. | 28.53 Million USD | -2108.285% |
| Adagene Inc. | 45.16 Million USD | -1294.88% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -348574.329% |
| Quantum-Si incorporated | 26.63 Million USD | -2265.882% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 9.678% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -20608.984% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -448.062% |
| SciSparc Ltd. | 1.59 Million USD | -39402.069% |
| Vericel Corporation | 127.7 Million USD | -393.37% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -11222.013% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -638.135% |
| Generation Bio Co. | 171.63 Million USD | -267.102% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5355.048% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1406.199% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -149.332% |
| Invivyd, Inc. | 51.71 Million USD | -1118.374% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -585.017% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -9585.376% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -734.558% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -61609.892% |
| 2seventy bio, Inc. | 310.12 Million USD | -103.162% |
| ADMA Biologics, Inc. | 193.97 Million USD | -224.812% |
| Clene Inc. | 38.95 Million USD | -1517.566% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1643.726% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -145.182% |
| GeoVax Labs, Inc. | 3.51 Million USD | -17799.98% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -231.151% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -5073.034% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -217.694% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -5066.612% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1209.592% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1092.366% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -70.353% |
| Evaxion Biotech A/S | 17.61 Million USD | -3476.323% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -291.513% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -311.303% |
| Trevena, Inc. | 48.26 Million USD | -1205.495% |
| Surrozen, Inc. | 8.14 Million USD | -7635.519% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2817.611% |
| Cingulate Inc. | 10.36 Million USD | -5981.133% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -22811.2% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1589.526% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -17467.391% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4691.316% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -98.631% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2435.547% |
| Clearmind Medicine Inc. | 3.61 Million USD | -17353.092% |
| Kronos Bio, Inc. | 54.2 Million USD | -1062.447% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1239.324% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2668.301% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3039.146% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2678.468% |
| ImmunityBio, Inc. | 1.09 Billion USD | 42.217% |
| Korro Bio, Inc. | 51.75 Million USD | -1117.456% |
| Kineta, Inc. | 7.22 Million USD | -8624.148% |
| BioVie Inc. | 9.7 Million USD | -6394.017% |
| Codexis, Inc. | 49.94 Million USD | -1161.478% |
| Celularity Inc. | 102.92 Million USD | -512.129% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -554.626% |
| Celcuity Inc. | 51.45 Million USD | -1124.601% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -182422.871% |
| Cibus, Inc. | 206.11 Million USD | -205.68% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1383.362% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2292.111% |
| IN8bio, Inc. | 8.77 Million USD | -7082.604% |
| Kodiak Sciences Inc. | 213.59 Million USD | -194.983% |
| Annexon, Inc. | 47.11 Million USD | -1237.192% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -603.653% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -553.777% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4502.659% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 75.799% |
| Eyenovia, Inc. | 19.78 Million USD | -3085.284% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -255.792% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8102.812% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2514.457% |
| Arcellx, Inc. | 339.75 Million USD | -85.446% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -5195.495% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -156.601% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6488.497% |
| Moolec Science SA | 13.94 Million USD | -4418.049% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1360.09% |
| Geron Corporation | 146.12 Million USD | -331.172% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1146.85% |
| Royalty Pharma plc | 6.29 Billion USD | 89.995% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1484.015% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -213909.905% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -25509.178% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -233.089% |
| Humacyte, Inc. | 114.67 Million USD | -449.42% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2068.799% |
| 89bio, Inc. | 59.96 Million USD | -950.745% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2280.902% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -52580.435% |
| Genelux Corporation | 8.42 Million USD | -7382.874% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -9089.877% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -362.194% |
| Notable Labs, Ltd. | 4.42 Million USD | -14132.166% |
| Liquidia Corporation | 73.13 Million USD | -761.465% |
| Mustang Bio, Inc. | 17.61 Million USD | -3476.015% |
| Immunovant, Inc. | 48.95 Million USD | -1187.015% |
| Quantum-Si incorporated | 26.63 Million USD | -2265.882% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1541.503% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -20204.802% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -753.032% |
| Acasti Pharma Inc. | 11.55 Million USD | -5351.744% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2686.914% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -23077.48% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1608.539% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -46131.185% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -10235.597% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2436.976% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2617.641% |
| PepGen Inc. | 34.63 Million USD | -1719.347% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -5088.225% |
| United Therapeutics Corporation | 1.18 Billion USD | 46.705% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8921.449% |
| Solid Biosciences Inc. | 38.45 Million USD | -1538.302% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7262.905% |
| Immuneering Corporation | 12 Million USD | -5146.83% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -200646.197% |
| Silo Pharma, Inc. | 1.56 Million USD | -40049.751% |
| Belite Bio, Inc | 4.21 Million USD | -14862.194% |
| XOMA Corporation | 145.58 Million USD | -332.792% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -25849.671% |
| Bionomics Limited | 10.15 Million USD | -6102.139% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2831.73% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2649.784% |
| uniQure N.V. | 624.01 Million USD | -0.968% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4338.591% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -348574.329% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -270.222% |
| Forte Biosciences, Inc. | 3.66 Million USD | -17086.525% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -241687.837% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -9238.343% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8102.812% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3524.564% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5861.942% |
| Altimmune, Inc. | 16.54 Million USD | -3709.068% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -2.0% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2649.784% |
| Compugen Ltd. | 55.77 Million USD | -1029.642% |
| Peak Bio, Inc. | 20.75 Million USD | -2935.932% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -470.379% |
| Benitec Biopharma Inc. | 4.96 Million USD | -12597.662% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -299.168% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -738.133% |
| Zura Bio Limited | 21.29 Million USD | -2859.13% |
| PolyPid Ltd. | 17.46 Million USD | -3506.927% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -460.555% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -738.133% |
| Instil Bio, Inc. | 99.8 Million USD | -531.314% |
| argenx SE | 444.95 Million USD | -41.602% |
| Immunome, Inc. | 28.65 Million USD | -2098.541% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -7457.371% |
| Verona Pharma plc | 58.84 Million USD | -970.781% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4253.334% |
| Shattuck Labs, Inc. | 14.85 Million USD | -4140.245% |
| CervoMed Inc. | 2.59 Million USD | -24172.705% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -12826.918% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4847.063% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5880.617% |
| Moolec Science SA | 13.94 Million USD | -4418.049% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -26785.297% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1033.294% |
| AnaptysBio, Inc. | 364.28 Million USD | -72.957% |
| Design Therapeutics, Inc. | 11.95 Million USD | -5169.806% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4867.345% |
| NeurAxis, Inc. | 1.91 Million USD | -32840.093% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1518.521% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4625.553% |
| Achilles Therapeutics plc | 19.08 Million USD | -3200.98% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4253.334% |
| 180 Life Sciences Corp. | 5.38 Million USD | -11595.444% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2571.097% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2668.301% |
| Nutriband Inc. | 1.07 Million USD | -58297.155% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1959.148% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -4241.934% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -57.014% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1840.252% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4728.365% |
| Palisade Bio, Inc. | 2.73 Million USD | -22903.213% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -11894.251% |
| Beam Therapeutics Inc. | 478.38 Million USD | -31.705% |
| Neurogene Inc. | 36.54 Million USD | -1623.872% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -58.326% |
| AEON Biopharma, Inc. | 159.88 Million USD | -294.06% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1222.262% |
| Sesen Bio, Inc. | 30.98 Million USD | -1933.495% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2326.94% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -8187.82% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -221.888% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -228.058% |
| Athira Pharma, Inc. | 30.05 Million USD | -1996.211% |
| Vaccinex, Inc. | 5.94 Million USD | -10503.467% |
| HCW Biologics Inc. | 15.05 Million USD | -4085.891% |
| XOMA Corporation | 145.58 Million USD | -332.792% |
| Nektar Therapeutics | 267.04 Million USD | -135.936% |
| Arvinas, Inc. | 644.6 Million USD | 2.256% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3452.999% |
| Merus N.V. | 102.15 Million USD | -516.791% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -330.515% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -562.382% |
| Rezolute, Inc. | 11.73 Million USD | -5269.507% |
| Clene Inc. | 38.95 Million USD | -1517.566% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -22027.64% |
| BeyondSpring Inc. | 48.26 Million USD | -1205.306% |
| Synlogic, Inc. | 32.89 Million USD | -1815.361% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -4211.627% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -38459.241% |
| Peak Bio, Inc. | 20.75 Million USD | -2935.932% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -892.858% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1486.488% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -67.282% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -532.785% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -145502.067% |
| MannKind Corporation | 721.36 Million USD | 12.658% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2720.945% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -30104.123% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -514.151% |
| Gossamer Bio, Inc. | 249.14 Million USD | -152.886% |
| CohBar, Inc. | 1.03 Million USD | -60855.383% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5794.452% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3207.738% |
| Legend Biotech Corporation | 589.93 Million USD | -6.802% |
| Mural Oncology plc | 37.92 Million USD | -1561.195% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -375.028% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -27349.537% |
| Disc Medicine, Inc. | 22.87 Million USD | -2654.352% |
| Champions Oncology, Inc. | 28.03 Million USD | -2147.398% |
| REGENXBIO Inc. | 262.22 Million USD | -140.271% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -18655.343% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4926.791% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4590.854% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2871.271% |
| Vaxart, Inc. | 34.02 Million USD | -1751.75% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2990.146% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2108.26% |
| Cellectis S.A. | 249.57 Million USD | -152.452% |
| Longeveron Inc. | 5.33 Million USD | -11705.471% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1406.631% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 73.805% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -943.695% |
| Revolution Medicines, Inc. | 262.39 Million USD | -140.116% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -29803.085% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -7204.173% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -5239.022% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4386.634% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -29191.399% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 87.765% |
| Denali Therapeutics Inc. | 122.96 Million USD | -412.396% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -11222.013% |
| Veru Inc. | 32.81 Million USD | -1820.165% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -9072.485% |
| Cingulate Inc. | 10.36 Million USD | -5981.133% |
| Passage Bio, Inc. | 39.26 Million USD | -1504.753% |
| Context Therapeutics Inc. | 4.19 Million USD | -14931.031% |
| Exicure, Inc. | 8.54 Million USD | -7269.961% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2035.211% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5908.564% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2758.573% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -286.572% |
| Nuvalent, Inc. | 31.82 Million USD | -1879.882% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -9804.039% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -899.743% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3400.322% |
| OmniAb, Inc. | 87.4 Million USD | -620.89% |
| Anew Medical, Inc. | 8.24 Million USD | -7544.666% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1545.529% |
| Lipocine Inc. | 2.63 Million USD | -23841.749% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2298.211% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1466.841% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2264.922% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -631.316% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -11565.58% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -661.427% |
| Ocugen, Inc. | 23.98 Million USD | -2527.103% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1257.679% |
| Q32 Bio Inc. | 233.12 Million USD | -170.263% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6849.68% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1077.634% |
| Equillium, Inc. | 27.95 Million USD | -2153.668% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -204.977% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -11097.717% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -10173.297% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -300.479% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -807.433% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -6216.877% |
| Dominari Holdings Inc. | 4.63 Million USD | -13493.484% |
| Edesa Biotech, Inc. | 1.84 Million USD | -34111.845% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2030.95% |
| Bio-Techne Corporation | 744.34 Million USD | 15.353% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -399.653% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -82.914% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1452.823% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2075.84% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -582.176% |
| Nkarta, Inc. | 105.6 Million USD | -496.646% |
| BioCardia, Inc. | 4.59 Million USD | -13626.754% |
| Iterum Therapeutics plc | 32.66 Million USD | -1829.025% |